Expression of the retinoblastoma gene product in renal tumors

Anticancer Research

Volumn 16, Issue 2, 1996, Pages 549-556

  Presti Jr , Joseph C ^a   Reuter, Victor E ^b   Cordon Cardo, Carlos ^b   Motzer, Robert J ^c   Albino, Anthony P ^b   Jhanwar, Suresh C ^b   Nanus, David M ^b,c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Department of Population Medicine and Diagnostic Sciences   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Kidney neoplasm; Retinoblastoma gene

Indexed keywords

ARTICLE; GENE EXPRESSION; GENE REARRANGEMENT; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; KIDNEY CANCER; KIDNEY TUMOR; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; METASTASIS; PRIORITY JOURNAL; SOUTHERN BLOTTING; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; CARCINOMA, PAPILLARY; CARCINOMA, RENAL CELL; GENES, RETINOBLASTOMA; HUMANS; KIDNEY NEOPLASMS; NEOPLASM PROTEINS; RETINOBLASTOMA PROTEIN; TUMOR CELLS, CULTURED;

EID: 0029942347     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Lee WH, Chen PL, Riley DJ: Regulatory networks of the retinoblastoma protein. Annals of the New York Academy of Sciences 752: 432-445, 1995.
2. Weinberg RA: The retinoblastoma protein and cell cycle control. Cell 81: 323-330, 1995.
3. Cox LA, Chen G, Lee EY: Tumor suppressor genes and their roles in breast cancer. Breast Cancer Res & Treat 32: 19-38, 1994.
4. Xu HJ, Hu SX, Cagle PT, Moore GE, Benedict WF: Absence of retinoblastoma protein expression in primary non-small cell lung carcinomas. Cancer Res 51: 2735-2739, 1991.
5. Reissmann PT, Koga H, Takahashi R, Figlin RA, Holmes EC, Piantadosi, S, Cordon-Cardo C, Slamon DJ: Inactivation of the retinoblastoma susceptibility gene in non-small-cell lung cancer. The Lung Cancer Study Group. Oncogene 8: 1913-1919, 1993.
6. Cairns P, Proctor AJ, Knowles MA: Loss of heterozygosity at the RB locus is frequent and correlates with muscle invasion in bladder carcinoma. Oncogene 6: 2305-2309, 1991.
7. Miyamoto H, Shuin T, Torigoe S, Iwasaki Y, Kubota Y: Retinoblastoma gene mutations in primary human bladder cancer. Br J Cancer 71: 831-835, 1995.
8. Wadayama B, Toguchida J, Shimizu T, Ishizaki K, Sasaki MS, Kotoura Y, Yamamuro T: Mutation spectrum of the retinoblastoma gene in osteosarcomas. Cancer Res 54: 3042-3048, 1994.
9. Xu HJ, Quinlan DC, Davidson AG, Hu SX, Summers CL, Li J, Benedict, WF. Altered retinoblastoma protein expression and prognosis in early-stage non-small-cell lung carcinoma. J Natl Cancer Inst 86: 695-699, 1994.
10. Wingo PA, Tong T, Bolden S: Cancer statistics, 1995. CA 45: 8-30, 1995.
11. Ishikawa J, Xu HJ, Hu SX, Yandell DW, Maeda S, Kamidono S, Benedict, WF, Takahashi R: Inactivation of the retinoblastoma gene in human bladder and renal cell carcinomas. Cancer Res 51: 5736-5743, 1991.
12. Suzuki Y, Tamura G, Maesawa C, Fujioka T, Kubo T, Satodate R: Analysis of genetic alterations in renal cell carcinoma using the polymerase chain reaction. Virchows Arch. 424: 453-457, 1994.
13. Lipponen P, Eskelinen M, Syrjanen K: Expression of tumour-suppressor gene Rb, apoptosis-suppressing protein Bcl-2 and c-Myc have no independent prognostic value in renal adenocarcinoma. Br J Cancer 71: 863-867, 1995.
14. Walther MM, Gnarra JR, Erwood L, Xu HJ, Florence C, Anglard P, Hu SX, King C, Trahan E, Hurley K, Sens D, Venzon O, Liu S, Jaffe GS, Beredict WF, Linehan WM: Loss of heterozygosity occurs centromeric to RB without associated abnormalities in the retinoblastoma gene in tumors from patients with metastatic renal cell carcinoma. J Urol 153: 2050-2054, 1995.
15. Ebert T, Bander NH, Finstad CL, Ramsawak RD, Old LJ: Establishment and characterization of human renal cancer and normal kidney cell lines. Cancer Res 50: 5531-5536, 1990.
16. Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 76: 4350-4354, 1979.
17. Beahrs OH, Henson DE, Hutter RVP, Myers MH: Manual for Staging of Cancer. Philadelphia: J.B. Lippincott, 1988.
18. Presti JC, Jr., Rao PH, Chen O, Reuter VE, Li FP, Fair WR, Jhanwar SC: Histopathological, cytogenetic, and molecular characterization of renal cortical tumors. Cancer Res 51: 1544-1552, 1991.
19. Feinberg AP, Vogelstein B: A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Analyt Biochem 132:6-13, 1982.
20. Van Noorden S, Polak JM: Immunocytochemistry today. In: Immunocytochemistry-Practical applications in pathology and biology (Polak JM, Van Noordern S, eds). Bristol, England, John Wright & Sons Ltd., 1983, pp 11-42.
21. Fleiss JL: Anonymous Statistical methods for rates and proportions. New York: Wiley, 1973, pp 24-26.
22. Decker HJ, Wullich B, Whaley JM, Herrera G, Klauck SM, Sandberg AA, Yandell DW, Seizinger BR: Cytogenetic and molecular studies of a familial renal cell carcinoma. Cancer Genet Cytogenet 63: 25-31, 1992.
23. Xu HJ, Hu SX, Benedict WF: Lack of nuclear RB protein staining in G0/middle G1 cells: correlation to changes in total RB protein level. Oncogene 6: 1139-1146, 1991.
24. Dickerson GR, Colvin RB: Pathology of renal tumors. In: Diagnosis and management of genitourinary cancer (Skinner DG, ed). Philadelphia, W.B. Saunders Co. 1988, pp 118-149.
25. Mancilla-Jimenez R, Stanley RJ, Blath RA: Papillary renal cell carcinoma: a clinical, radiologic, and pathologic study of 34 cases. Cancer 38: 2469-2480, 1976.